Valsamo Anagnostou, Co-Director of Thoracic Oncology Precision Medicine Center of Excellence and Division of Upper Aerodigestive Malignancies and Alex Grass Professor of Oncology at Johns Hopkins University School of Medicine, shared a post on LinkedIn:
“Excellent collection on lung cancer from Nature Outlook, featuring our study on how radiotherapy enhances IO sensitivity in immunologically cold lung tumors, highlighting the abscopal effect and the boost in systemic immune response due to radiotherapy.”
Title: Combination of pembrolizumab and radiotherapy induces systemic antitumor immune responses in immunologically cold non-small cell lung cancer
Authors: Justin Huang, Willemijn S. M. E. Theelen, Zineb Belcaid, Mimi Najjar, Daphne van der Geest, Dipika Singh, Christopher Cherry, Archana Balan, James R. White, Jaime Wehr, Rachel Karchin, Noushin Niknafs, Michel M. van den Heuvel, Victor E. Velculescu, Kellie N. Smith, Paul Baas, Valsamo Anagnostou
Read The Full Article
